| 영문 | peptide | 한글 | 펩티드 |
|---|---|---|---|
| 설명 | 두 개이상의 아미노산 분자 사이에서, 한쪽의 아미노기와 다른 쪽의 카르복실기가 물 분자를 잃으면서 축합하여 이루는 아미드 결합아미노산의 수가 2, 3, … 인 경우, 각각 디펩티드, 트리펩티드, …등으로 부르며, 여러 개의 아미노산으로 구성되는 것을 올리고펩티드, 이보다 큰 것을 폴리펩티드라고 한다. 직쇄상의 것이 많지만, 환상 구조를 갖는 펩티드도 있다. 저분자의 펩티드는 물, 산, 알칼리 따위에 잘 녹고 알코올에는 녹지 않으나, 고분자의 펩티드는 물에 잘 녹지 않고 단백질과 성질이 비슷하다. 뇌하수체호르몬, 브라디키닌 등과 같이 생리적기능이 현저한 것은 생리활성펩티드(bioactive peptide)라고 한다. |
||
| S | Greek capital letter sigma; syphilis; summation of series |
|---|---|
| s | Greek lower case letter sigma; conductivity; cross section; millisecond; molecular type or bond; pop... |
| SR | sarcoplasmic reticulum; saturation recovery; scanning radiometer; screen; secretion rate; sedimentat... |
| C-Peptide | Connecting Peptide |
| ERP | early receptor potential; effective refractory period; elodoisin-related peptide; endoscopic retrogr... |
| sigma 54 | sigma N |
|---|---|
| sigma S | sigma factor |
| s | E-sigma |
| C-peptide | connecting peptide |
| LAP | 1-latency associated peptide |
corticotropin-releasing factor (부신 피질 호르몬 유리 요소, 부신 피질 호르몬 유리 인자
| sigma peptide | A peptide with one end bonded to a point within the chain, usually by means of the disulfide group of a cystine residue, so that only one end of the peptide is free; so called since the peptide chain has then the rough shape of the Greek letter sigma; e.g., oxytocin. (05 Mar 2000) |
|---|
| receptors, sigma | A class of cell surface receptors recognised by its pharmacological profile. Sigma receptors were originally considered to be opioid receptors because they bind certain synthetic opioids. However they also interact with a variety of other psychoactive drugs, and their endogenous ligand is not known (although they can react to certain endogenous steroids). Sigma receptors are found in the immune, endocrine, and nervous systems, and in some peripheral tissues. (12 Dec 1998) |
|---|---|
| sigma | The 18th letter of the Greek alphabet, σ. (05 Mar 2000) |
| sigma bond | <chemistry> A bond formed from the overlap of either two s-orbitals or two hybrid orbitals such as sp3 or sp2 orbitals. (09 Jan 1998) |
| sigma effect | The decrease in apparent viscosity that occurs when a suspension, such as blood, is made to flow through a tube of smaller diameter; observed in tubes less than about 0.3 mm in diameter. Synonym: sigma effect. (05 Mar 2000) |
| sigma factor | Initiation factor (86 kD) that binds to E. Coli DNA dependent RNA polymerase and promotes attachment to specific initiation sites on DNA. Following attachment, the sigma factor is released. (18 Nov 1997) |
| alpha-aminoacyl-peptide hydrolases | <enzyme> Registry number: EC 3.4.11. (12 Dec 1998) |
| anionic neutrophil activating peptide | <cytokine> A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes. It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. Il-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4. Acronym: IL-8 (12 Dec 1998) |
| antibiotics, peptide | Antibiotics whose structure contains one or more peptides, usually cyclic. They are generally effective against gram-positive bacteria and act by inhibiting peptidoglycan synthesis in bacterial cell walls. (12 Dec 1998) |
| atrial natriuretic peptide | <hormone> This cardiac hormone (28 amino acid residues) regulates salt and water balance in body fluids and blood pressure, it has potential as a medication to treat heart and kidney failure and the buildup of excess fluid in tissue. (09 Oct 1997) |
| bradykinin-potentiating peptide | <chemical> 2-l-tryptophan-3-de-l-leucine-4-de-l-proline-8-l-glutamine bradykinin potentiator b. A synthetic nonapeptide with the sequence pyr-trp-pro-arg-pro-gln-ile-pro-pro, which is identical to that of the peptide from the venom of the snake, bothrops jararaca. It acts as an inhibitor of kininase II and angiotensin I and has been proposed as an antihypertensive agent. Pharmacological action: angiotensin-converting enzyme inhibitors, antihypertensive agents. Chemical name: Bradykinin potentiator B, 2-L-tryptophan-3-de-L-leucine-4-de-L-proline-8-L-glutamine- (12 Dec 1998) |
| brain natriuretic peptide | <hormone, protein> Brain peptide that induces diuresis, related to atrial natriuretic peptide. (18 Nov 1997) |
| calcitonin gene-related peptide | <protein> A second product transcribed from the calcitonin gene. Calcitonin gene related peptide is found in a number of tissues including nervous tissue. It is a vasodilator that may participate in the cutaneous triple response. It is a neuropeptide of 37 amino acids with structural homology to salmon calcitonin. Co-localises with substance P in neurons. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in neural tissue of the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator. Intracerebral administration leads to a rise in noradrenergic sympathetic outflow, a rise in blood pressure and a fall in gastric secretion. Acronym: CGRP (05 May 2002) |
| vasoactive intestinal peptide | <gastroenterology, protein> Peptide of 28 amino acids, originally isolated from porcine intestine, but later found in the central nervous system where it acts as a neuropeptide and is released by specific interneurons. May also affect behaviour of cells of the immune system. Acronym: VIP (05 Jan 1998) |
| gastrin-releasing peptide | <hormone> A regulatory peptide (27 amino acids) thought to be the mammalian equivalent of bombesin. It elicits gastrin release and regulates gastric acid secretion and motor function. It causes bronchoconstriction and vasodilation in the respiratory tract and stimulates the growth and mitogenesis of cells in culture. Once released from nerves in the antrum of the stomach, the neuropeptide stimulates release of gastrin from the g cells. Chemical name: Gastrin-releasing peptide (12 Dec 1998) |
| receptors, calcitonin gene-related peptide | Cell surface proteins that bind calcitonin gene-related peptide (cgrp) with high affinity and trigger intracellular changes which influence the behaviour of cells. Cgrp receptors are present in both the central nervous system and the periphery and are not the same as calcitonin receptors. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|